Please read and agree to the
terms and conditions
of this site.
I agree
COVID-19
/news
Clear filters and search
Format
photo
Tags
/markets
/money
markets
money
What
believe
buying
covid
currently
17
×
fact
good
high
near
17
×
opportunity
17
×
pre
17
×
present
stock
time
trades
coronavirus
february
pandemic
buy
hit
world
company
levels
march
focused
pharmaceuticals
products
rebound
best
biotechnology
diseases
here’s
industry
known
looks
pharmaceutical
ride
services
volatile
acad
acadia
Language
unset
Current search:
pre
×
opportunity
×
near
×
currently
×
@forbes.com
3 years ago
Down 30% Since Pre-Covid High, Is Cracker Barrel Stock A Buy?
@forbes.com
3 years ago
Is A Recovery Imminent In Haemonetics Stock After Falling 40% This Year?
@forbes.com
3 years ago
Should You Buy Mercury Systems At Around $50 Levels?
@forbes.com
4 years ago
Should You Buy uniQure Stock At $30?
@forbes.com
4 years ago
Should You Buy CVS Health Stock At $70?
@forbes.com
3 years ago
Should You Buy Baxter Stock Around $80?
@forbes.com
3 years ago
Kirby Stock Performance In The Pandemic vs 2008
@forbes.com
3 years ago
Will Teva Stock Rebound After A 10% Fall In A Month?
@forbes.com
4 years ago
Down 40% From Recent Highs Can Inovio Pharmaceuticals Stock Rebound?
@forbes.com
3 years ago
Vertex Pharmaceuticals Stock Is Likely To Rebound From $180 Levels Currently
@forbes.com
3 years ago
Here’s Why Perrigo Stock May See Higher Levels In The Near Term
@forbes.com
4 years ago
Should You Buy Xerox Stock At $24 Levels?
@forbes.com
4 years ago
ACADIA Pharmaceuticals Stock Now Looks Oversold At $27 Levels
@forbes.com
3 years ago
What’s Next For Steelcase Stock?
@forbes.com
3 years ago
Is CMC Materials Stock A Buy At $120 Levels?
@forbes.com
4 years ago
Should You Buy BioMarin Pharmaceutical Stock At $78?
@forbes.com
4 years ago
Here’s Why Biogen Stock Can Offer Over 35% Gains